1. Home
  2. MDXH vs SXTC Comparison

MDXH vs SXTC Comparison

Compare MDXH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.35

Market Cap

203.4M

Sector

N/A

ML Signal

HOLD

Logo China SXT Pharmaceuticals Inc.

SXTC

China SXT Pharmaceuticals Inc.

N/A

Current Price

$1.40

Market Cap

184.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDXH
SXTC
Founded
2003
2005
Country
Belgium
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.4M
184.5M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
MDXH
SXTC
Price
$3.35
$1.40
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
187.0K
224.1K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$103,069,000.00
$1,740,907.00
Revenue This Year
$23.34
N/A
Revenue Next Year
$22.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.68
N/A
52 Week Low
$1.35
$0.95
52 Week High
$5.33
$7.84

Technical Indicators

Market Signals
Indicator
MDXH
SXTC
Relative Strength Index (RSI) 36.56 50.67
Support Level $3.31 $1.35
Resistance Level $3.74 $1.42
Average True Range (ATR) 0.18 0.06
MACD 0.01 0.00
Stochastic Oscillator 15.97 45.00

Price Performance

Historical Comparison
MDXH
SXTC

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: